615 related articles for article (PubMed ID: 10769189)
1. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
[TBL] [Abstract][Full Text] [Related]
2. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
Zhorov BS; Folkman EV; Ananthanarayanan VS
Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158
[TBL] [Abstract][Full Text] [Related]
3. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
Peterson BZ; Catterall WA
Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
[TBL] [Abstract][Full Text] [Related]
4. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
[TBL] [Abstract][Full Text] [Related]
5. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
Suh-Kim H; Wei X; Birnbaumer L
Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
[TBL] [Abstract][Full Text] [Related]
6. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.
Hockerman GH; Peterson BZ; Sharp E; Tanada TN; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14906-11. PubMed ID: 9405712
[TBL] [Abstract][Full Text] [Related]
7. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
[TBL] [Abstract][Full Text] [Related]
8. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
[TBL] [Abstract][Full Text] [Related]
9. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.
Cosconati S; Marinelli L; Lavecchia A; Novellino E
J Med Chem; 2007 Apr; 50(7):1504-13. PubMed ID: 17335186
[TBL] [Abstract][Full Text] [Related]
11. Expression of dihydropyridine binding sites in renal epithelial cells.
O'Neil RG; Reid JM; Williams RL; Karin NJ
Biochem Biophys Res Commun; 1997 Aug; 237(1):41-5. PubMed ID: 9266826
[TBL] [Abstract][Full Text] [Related]
12. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
He M; Bodi I; Mikala G; Schwartz A
J Biol Chem; 1997 Jan; 272(5):2629-33. PubMed ID: 9006896
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the smooth-muscle L-type Ca2+ channel alpha1 subunit (alpha1C-b) by the beta2a subunit: a peptide which inhibits binding of beta to the I-II linker of alpha1 induces functional uncoupling.
Hohaus A; Poteser M; Romanin C; Klugbauer N; Hofmann F; Morano I; Haase H; Groschner K
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):657-65. PubMed ID: 10839999
[TBL] [Abstract][Full Text] [Related]
14. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188.
Sinnegger MJ; Wang Z; Grabner M; Hering S; Striessnig J; Glossmann H; Mitterdorfer J
J Biol Chem; 1997 Oct; 272(44):27686-93. PubMed ID: 9346909
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent calcium channels.
Lacinová L
Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivities of CaV1.2 IIS5-S6 mutants to 1,4-dihydropyridine analogs.
Hui K; Kwok TC; Kostelecki W; Leen J; Roy PJ; Feng ZP
Eur J Pharmacol; 2009 Jan; 602(2-3):255-61. PubMed ID: 19068212
[TBL] [Abstract][Full Text] [Related]
17. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Mason RP; Moisey DM; Shajenko L
Mol Pharmacol; 1992 Feb; 41(2):315-21. PubMed ID: 1531693
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
20. A specific tryptophan in the I-II linker is a key determinant of beta-subunit binding and modulation in Ca(V)2.3 calcium channels.
Berrou L; Klein H; Bernatchez G; Parent L
Biophys J; 2002 Sep; 83(3):1429-42. PubMed ID: 12202369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
